| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | BIOTIME INC | 20,084 | 12,000 | 0.00% | ||
| 2 | CYCLACEL PHARMACEUTICALS INC | 13,253 | 76,000 | 0.00% | ||
| 3 | APTOSE BIOSCIENCES INC | 33,397 | 100,000 | 0.00% | ||
| 4 | CHEMOCENTRYX INC | 49,064 | 122,000 | 0.00% | ||
| 5 | ACHAOGEN INC COM | 100,000 | 276,000 | 0.00% | ||
| 6 | LA JOLLA PHARMACEUTICAL CO | 13,746 | 287,000 | 0.00% | ||
| 7 | Foundation Medicine | 20,892 | 380,000 | 0.00% | ||
| 8 | DISCOVERY LABORATORIES INC N | 254,973 | 426,000 | 0.00% | ||
| 9 | RITTER PHARMACEUTICALS INC | 400,000 | 452,000 | 0.00% | ||
| 10 | CHIMERIX INC | 115,216 | 589,000 | 0.01% | ||
| 11 | Aldeyra Therapeutics Inc | 142,000 | 595,000 | 0.01% | ||
| 12 | BIODELIVERY SCIENCES INTL IN | 210,021 | 678,000 | 0.01% | ||
| 13 | ALNYLAM PHARMACEUTICALS INC | 11,340 | 712,000 | 0.01% | ||
| 14 | ARBUTUS BIOPHARMA CORP | 180,582 | 746,000 | 0.01% | ||
| 15 | ACCELERON PHARMA INC | 28,765 | 759,000 | 0.01% | ||
| 16 | FIVE PRIME THERAPEUTICS INC | 19,247 | 782,000 | 0.01% | ||
| 17 | ADAPTIMMUNE THERAPEUTICS PLC | 100,000 | 813,000 | 0.01% | ||
| 18 | TENAX THERAPEUTICS INC | 420,000 | 861,000 | 0.01% | ||
| 19 | GW PHARMACEUTICALS PLC | 15,000 | 1,082,000 | 0.01% | ||
| 20 | PALATIN TECHNOLOGIES INC COM | 2,050,000 | 1,107,000 | 0.01% | ||
| 21 | AMARIN CORP PLC | 801,860 | 1,227,000 | 0.01% | ||
| 22 | ASSEMBLY BIOSCIENCES INC | 250,000 | 1,255,000 | 0.01% | ||
| 23 | MAST THERAPEUTICS INC COM | 4,797,442 | 1,309,000 | 0.01% | ||
| 24 | Sierra Oncology, Inc. | 200,000 | 1,348,000 | 0.01% | ||
| 25 | CELLECTIS S A | 50,000 | 1,375,000 | 0.01% | ||
| 26 | DYNAVAX TECHNOLOGIES CORP | 75,000 | 1,443,000 | 0.02% | ||
| 27 | AFFIMED N V COM | 400,000 | 1,496,000 | 0.02% | ||
| 28 | OPHTHOTECH CORP | 35,649 | 1,507,000 | 0.02% | ||
| 29 | STEMLINE THERAPEUTICS INC | 333,497 | 1,554,000 | 0.02% | ||
| 30 | CYTRX CORP | 659,995 | 1,769,000 | 0.02% | ||
| 31 | MEDIWOUND ORD | 226,000 | 1,824,000 | 0.02% | ||
| 32 | IRONWOOD PHARMACEUTICALS INC | 169,163 | 1,851,000 | 0.02% | ||
| 33 | KARYOPHARM THERAPEUTICS INC COM | 216,990 | 1,936,000 | 0.02% | ||
| 34 | IMMUNE DESIGN CORP | 148,937 | 1,936,000 | 0.02% | ||
| 35 | TRILLIUM THERAPEUTICS INC | 211,792 | 1,959,000 | 0.02% | ||
| 36 | AURINIA PHARMACEUTICALS INC | 711,499 | 2,082,000 | 0.02% | ||
| 37 | ENANTA PHARMACEUTICALS INC | 75,357 | 2,213,000 | 0.02% | ||
| 38 | Proteon Therapeutics Inc | 298,591 | 2,311,000 | 0.02% | ||
| 39 | IONIS PHARMACEUTICALS INC COM | 57,140 | 2,314,000 | 0.02% | ||
| 40 | PROTALIX BIOTHERAPEUTICS INC | 3,423,000 | 2,334,000 | 0.02% | PRN | |
| 41 | ARRAY BIOPHARMA INC 3 06/01/2020 | 3,000,000 | 2,382,000 | 0.03% | PRN | |
| 42 | Sunesis Pharmaceuticals I | 4,450,000 | 2,403,000 | 0.03% | ||
| 43 | ADAMAS PHARMACEUTICALS INC | 172,630 | 2,496,000 | 0.03% | ||
| 44 | UNIQURE NV | 230,000 | 2,732,000 | 0.03% | ||
| 45 | INVIVO THERAPEUTICS HLDGS CORPORATION COM NEW | 400,000 | 2,792,000 | 0.03% | ||
| 46 | EPIZYME INC COM | 232,481 | 2,818,000 | 0.03% | ||
| 47 | OSIRIS THERAPEUTICS INC NEW COM | 499,193 | 2,850,000 | 0.03% | ||
| 48 | JUNO THERAPEUTICS INC COM | 80,000 | 3,047,000 | 0.03% | ||
| 49 | ADR - Nabriva Therapeutics AG- Usd | 350,000 | 3,136,000 | 0.03% | ||
| 50 | Curis, Inc | 1,999,303 | 3,219,000 | 0.03% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-16-102596, filed 2016.05.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
